Canton Strategic Holdings (CNTN) EBIT Growth (1y) (2022 - 2026)
Canton Strategic Holdings (CNTN) EBIT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 100.00% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 12.69% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 75.16% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1.27% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -347.04% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -230.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 80.62% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -1,347.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,347.71% |
| Dec 31, 2025 | 38.60% |
| Sep 30, 2025 | 45.84% |
| Jun 30, 2025 | 22.01% |
| Mar 31, 2025 | -8.49% |
| Dec 31, 2024 | -50.67% |
| Sep 30, 2024 | -109.51% |
| Jun 30, 2024 | -0.37% |
| Mar 31, 2024 | 13.52% |
| Dec 31, 2023 | -43.29% |
| Sep 30, 2023 | 13.27% |
| Jun 30, 2023 | -44.46% |
| Mar 31, 2023 | -100.89% |
| Dec 31, 2022 | -1,638.74% |
| Sep 30, 2022 | -293.17% |
| Jun 30, 2022 | -49.11% |
| Mar 31, 2022 | 7.93% |